These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15309694)

  • 21. Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting.
    Feldman DS; Sun B
    Heart Fail Rev; 2004 Jul; 9(3):203-8. PubMed ID: 15809818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis.
    Mitaka C; Kudo T; Haraguchi G; Tomita M
    Crit Care; 2011; 15(5):R258. PubMed ID: 22032777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor?
    Brunner-La Rocca HP; Woods RL; Kaye DM; Hastings J; Thomas CJ; Lambert E; Esler MD
    J Hypertens; 2002 Jun; 20(6):1195-201. PubMed ID: 12023691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide secretion without change in intra-cardiac pressure.
    Puelacher C; Rudez J; Twerenbold R; Moreno Weidmann Z; Osswald S; Eckstein F; Lurati-Buse G; Pargger H; Mueller C
    Clin Biochem; 2015 Mar; 48(4-5):318-21. PubMed ID: 25526883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.
    Yancy CW
    Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of brain natriuretic peptide improves cardiac function following operations using extracorporeal circulation in an animal model.
    Bail DH; Steger V; Heinzelmann U; Schiller S; Geim AI; Brüllmann B; Ziemer G
    Clin Sci (Lond); 2007 Mar; 112(5):315-24. PubMed ID: 17073825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Pre-Clinical Diastolic Dysfunction (Stage B Heart Failure).
    Wan SH; McKie PM; Schirger JA; Slusser JP; Hodge DO; Redfield MM; Burnett JC; Chen HH
    JACC Heart Fail; 2016 Jul; 4(7):539-547. PubMed ID: 26874387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential.
    Burger MR; Burger AJ
    Curr Opin Investig Drugs; 2001 Jul; 2(7):929-35. PubMed ID: 11757793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and physiological effects of nesiritide.
    Reichert S; Ignaszewski A
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):15B-8B. PubMed ID: 18629383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nesiritide: past, present, and future.
    Burger AJ; Burger MR
    Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A correlation between atrial natriuretic peptide, brain natriuretic peptide, and perioperative cardiac and renal functions in open heart surgery].
    Hata M; Masato O; Cho S; Narata M; Hata H; Inoue T; Sezai Y
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Nov; 45(11):1797-802. PubMed ID: 9430955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.
    Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS
    Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversibility of medically unresponsive pulmonary hypertension with nesiritide in a cardiac transplant recipient.
    Bhat G; Costea A
    ASAIO J; 2003; 49(5):608-10. PubMed ID: 14524574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nesiritide (BNP) in the management of postoperative cardiac patients.
    Moazami N; Damiano RJ; Bailey MS; Hess RL; Lawton JS; Moon MR; Pasque MK
    Ann Thorac Surg; 2003 Jun; 75(6):1974-6. PubMed ID: 12822655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
    Chen HH; Lainchbury JG; Harty GJ; Burnett JC
    Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nesiritide: a new drug for the treatment of decompensated heart failure.
    Elkayam U; Akhter MW; Tummala P; Khan S; Singh H
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):181-94. PubMed ID: 12232567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.